| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expense), net | -2,232 | 1,768 | 3,700 | -38,848 |
| Net loss | -18,990 | -21,330 | -21,825 | -68,591 |
| Earnings per share, basic | -0.13 | -0.15 | -0.15 | -0.48 |
| Earnings per share, diluted | -0.13 | -0.15 | -0.15 | -0.48 |
| Weighted average number of shares outstanding, basic | 145,559,604 | 145,091,474 | 144,787,971 | 144,345,781 |
| Weighted-average common stock outstanding - diluted (in shares) | 145,559,604 | 145,091,474 | 144,787,971 | 144,345,781 |
Applied Therapeutics, Inc. (APLT)
Applied Therapeutics, Inc. (APLT)